Royalty Pharma Plc
(NASDAQ) RPRX
Royalty Pharma Plc Financials at a Glance
Market Cap
$24.24B
Revenue (TTM)
$2.44B
Net Income (TTM)
$827.60M
EPS (TTM)
$1.91
P/E Ratio
28.64
Dividend
$0.91
Beta (Volatility)
0.47 (Low)
Dividend
$0.91
Beta (Volatility)
0.47 (Low)
Price
$56.22
Volume
6,979,837.868
Open
$54.60
Price
$56.22
Volume
6,979,837.868
Open
$54.60
Previous Close
$56.23
Daily Range
$54.60 - $56.29
52-Week Range
$34.08 - $56.50
Estimated Earnings Date
Aug 5, 2026
Dividend
$0.91
Beta (Volatility)
0.47 (Low)
Price
$56.22
Volume
6,979,837.868
Open
$54.60
Previous Close
$56.23
Daily Range
$54.60 - $56.29
52-Week Range
$34.08 - $56.50
Estimated Earnings Date
Aug 5, 2026
RPRX News
RPRX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Royalty Pharma Plc
Industry
Pharmaceuticals
Sector
Health CareEmployees
100
CEO
Pablo Gerardo Legorreta
Website
royaltypharma.comHeadquarters
New York, NY 10022, US
RPRX Financials
Key Financial Metrics (TTM)
Gross Margin
99.95%
Operating Margin
67.93%
Net Income Margin
33.91%
Return on Equity
12.67%
Return on Capital
10.11%
Return on Assets
4.18%
Earnings Yield
3.49%
Dividend Yield
1.66%
Payout Ratio
46.81%
Stock Overview
Market Cap
$24.24B
Shares Outstanding
443.27M
Volume
6.98M
Avg. Volume
3.67M
Financials (TTM)
Gross Profit
$2.44B
Operating Income
$1.66B
EBITDA
$1.70B
Operating Cash Flow
$2.65B
Capital Expenditure
$0.00
Free Cash Flow
$2.65B
Cash & ST Invst.
$608.30M
Total Debt
$8.96B
Royalty Pharma Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$630.58M
+11.0%
Gross Profit
$629.41M
+10.8%
Gross Margin
99.81%
N/A
Market Cap
$24.24B
N/A
Market Cap/Employee
$242.43M
N/A
Employees
100
N/A
Net Income
$295.00M
+23.8%
EBITDA
$563.15M
+12.9%
Quarterly Fundamentals
Total Cash
$608.30M
-66.5%
Total Debt
$8.96B
+17.6%
Accounts Receivable
$807.36M
+3294.4%
Inventory
$0.00
N/A
Long Term Debt
$8.58B
+29.6%
Short Term Debt
$380.00M
-61.9%
Return on Assets
4.18%
N/A
Return on Invested Capital
8.60%
N/A
Free Cash Flow
$760.54M
+27.6%
Operating Cash Flow
$760.54M
+27.6%